David Carr

David Carr, MD

  • Dermatology

Appointments: (614) 293-1707

About Me

Highlights

  • Rated in the top 10 percent of physicians in the nation for patient satisfaction, 2015
  • Best Doctor in America 2017

Specialties and conditions I treat

  • Dermatology
  • Skin Cancers
  • Dermatology
  • Mohs Surgery
  • Dysplastic Nevus Syndrome
  • Nevus, Intradermal
  • Nevus, Pigmented
  • Nevus
  • Skin Care
  • Moles

Education and training

Medical Degree

M.D.
Ohio State University College of Medicine
6/11/2006

Residency

Dermatology
Wright State University School of Medicine
7/1/2007 - 6/30/2010

More about my work

My background

Fellowship

Mohs Surgery
Northwestern Skin Cancer Institute
7/1/2010 - 6/30/2011

Board Certification

American Board of Dermatology
7/29/2010

My Department

Internal Medicine

My Division

Dermatology

Reviews

224 Patient Satisfaction Reviews

The patient satisfaction rating is an average of all responses to the six doctor communication related questions shown below from the Clinician and Group Consumer Assessment of Healthcare Providers and Systems survey. For additional information about the patient satisfaction survey, please visit our Patient Satisfaction Survey page
  • Overall
    4.9 out of 5
  • Explains Things Clearly 4.9
  • Listens Carefully 4.9
  • Gives Understandable Instructions 4.8
  • Knows My Medical History 4.6
  • Shows Respect 4.9
  • Time Spent Together 4.9

Consulting and Related Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.

As of 03/28/2017, Dr. Carr has reported no financial relationships with medical device, research and/or drug companies.